Symposium On Identification And Management Of The Candidate For Sudden Cardiac Death
Variations in and significance of systolic pressure during maximal exercise (treadmill) testing: Relation to severity of coronary artery disease and cardiac mortality*

https://doi.org/10.1016/S0002-9149(77)80037-4Get rights and content

Variations in clinical noninvasive systolic pressure at the point of symptom-limited exercise on a treadmill were examined in six groups of subjects: 5,459 men and 749 women classified into three categories each. Among the men, 2,532 were asymptomatic healthy, 592 were hypertensive and 1,586 had clinical manifestations of coronary heart disease (that is, typical angina pectoris, prior myocardial infarction or sudden cardiac arrest with resuscitation). Among the women, 244, 158 and 347 were in the corresponding clinical categories. None had had cardiac surgery; all had follow-up status ascertained by periodic mail questionnaires. Reported deaths were reviewed and classified by three cardiologists; 140 deaths were attributed to coronary heart disease, 118 of them in the men classified as having coronary heart disease. The majority of maximal systolic blood pressure readings were reported to the nearest centimeter rather than millimeter of pressure. Retesting of 156 persons from 1 to 32 months later showed that pressure values agreed within 10 percent in two thirds, the overall mean difference was only 8.6 mm Hg and the correlation at maximal exercise was superior to that of the resting observations just before exercise. Hypertensive patients had a significantly greater body weight than normotensive persons. Among men, the lowest maximal systolic pressure was observed in the group with coronary heart disease; among women, the lowest mean pressure was found in the healthy group. Patients with coronary heart disease were slightly older, and only the women showed a significant correlation in maximal pressure with age. Only 5 percent of the variation in maximal systolic pressure in the patients with coronary heart disease was due to a shortened duration of exercise. Maximal systolic pressures correlated fairly well (r = 0.46 to 0.68 for the various groups) with resting systolic pressure, and this relation was independent of the diagnosis of cardiovascular disease in both men and women. Relations between pressure and the number of stenotic coronary arteries and impaired ejection fraction at rest were examined in 22 men without and 182 men with coronary artery disease. Lower maximal systolic pressures were often associated with two or three vessel disease or reduced ejection fraction, or both.

The prognostic value of maximal systolic pressure for subsequent death due to coronary heart disease was examined in the men with coronary heart disease. The annual rate of sudden cardiac death decreased from 97.9 per 1,000 men to 25.3 and 6.6 per 1,000 men as the range of maximal systolic pressure increased from less than 140 to 140 to 199 and to 200 mm Hg or more, respectively. Cardiomegaly, Q waves in the resting electrocardiogram and persistent postexertional S-T depression were more common in men with the lowest systolic pressure at maximal exercise.

References (12)

There are more references available in the full text version of this article.

Cited by (100)

  • Variable prognostic value of blood pressure response to exercise

    2018, Journal of Cardiology
    Citation Excerpt :

    The major findings of the present study were that BP increase during exercise was significantly related to a lower occurrence of future cardiovascular morbidity/mortality in the total patients visiting a cardiovascular hospital, and that among the clinical variables, only peak VO2 showed a significant interaction with this role of BP response, suggesting a limitation in its predictive ability in patients with preserved exercise capacity. The prognostic significance of BP response to exercise has been reported in previous studies [5–7,9,12,13,17–20]. In healthy subjects, an exaggerated (exceeding the 80th–90th percentile) increase in systolic BP during exercise was reported to be associated with worse mortality and cardiovascular morbidity [4,7,17,19,20].

  • Upper normal values of blood pressure response to exercise in Olympic athletes

    2016, American Heart Journal
    Citation Excerpt :

    As expected, the physiologic response of CV system to exercise in athletes is characterized by an increase in heart rate and systolic BP (Figure 1), in response to the increased sympathetic drive, and associated to increased cardiac output.6,28–30 In our athlete's cohort, likely due to extensive peripheral vasodilation, the diastolic BP remains usually unchanged even at maximum exercise.6,28 The maximum systolic BPs we identified as threshold values (220 in male and 200 in female) are relatively higher than those reported by ESC (<210 mm Hg for men and <190 mm Hg for women) and ACC/AHA guidelines (<214 mm Hg); as an example, if the established ESC reference values were used in our population, a remarkably large number of healthy athletes (12% male and 21% female) would have been (mis)classified as abnormal BP responders.4,12

  • Exercise hypertension: an adverse prognosis?

    2009, Journal of the American Society of Hypertension
  • The Blood Pressure Response to Dynamic Exercise Testing: A Systematic Review

    2008, Progress in Cardiovascular Diseases
    Citation Excerpt :

    In population-based studies, lower maximal SBPs have often been associated with more severe CAD, reduced ejection fraction, or both. In a study that included 6208 subjects, Irving et al2 reported a decrease in the annual rate of sudden cardiac death from 98 to 25 to 7 per 1000 men as the range of maximal SBP increased from less than 140 to 140-199 to greater than 200 mm Hg, respectively. Cardiomegaly, Q waves in the resting ECG and persistent postexertional ST depression were found to be more common with patients with the lowest SBP values at maximal exercise.

View all citing articles on Scopus
*

This research was supported by Grant HL 13517 from the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Public Health Service, Bethesda, Maryland, the Poncin Scholarship Fund of the Seattle First National Bank, Seattle, Washington and a travel grant from the Wellcome Foundation, London, England.

*

Visiting scientist from the Department of Cardiology, the Royal Infirmary, Edinburgh, Scotland.

View full text